DK0503521T3 - Tørre, farmaceutiske lavdosispræparater - Google Patents

Tørre, farmaceutiske lavdosispræparater

Info

Publication number
DK0503521T3
DK0503521T3 DK92103963.2T DK92103963T DK0503521T3 DK 0503521 T3 DK0503521 T3 DK 0503521T3 DK 92103963 T DK92103963 T DK 92103963T DK 0503521 T3 DK0503521 T3 DK 0503521T3
Authority
DK
Denmark
Prior art keywords
dry
disclosed
weight
agent
pharmaceutical preparations
Prior art date
Application number
DK92103963.2T
Other languages
English (en)
Other versions
DK0503521T4 (da
Inventor
Pieter De Haan
Marcus Johannes Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0503521(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0503521T3 publication Critical patent/DK0503521T3/da
Publication of DK0503521T4 publication Critical patent/DK0503521T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92103963T 1991-03-12 1992-03-09 Törre, farmaceutiske lavdosispræparater DK0503521T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200524 1991-03-12

Publications (2)

Publication Number Publication Date
DK0503521T3 true DK0503521T3 (da) 1995-11-27
DK0503521T4 DK0503521T4 (da) 2005-12-05

Family

ID=8207548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92103963T DK0503521T4 (da) 1991-03-12 1992-03-09 Törre, farmaceutiske lavdosispræparater

Country Status (18)

Country Link
US (1) US5382434A (da)
EP (1) EP0503521B2 (da)
JP (1) JP3474210B2 (da)
KR (1) KR100198017B1 (da)
CN (1) CN1039086C (da)
AT (1) ATE125155T1 (da)
AU (1) AU651869B2 (da)
CA (1) CA2062428C (da)
DE (1) DE69203488T3 (da)
DK (1) DK0503521T4 (da)
ES (1) ES2077897T5 (da)
FI (1) FI100770B (da)
GR (1) GR3017737T3 (da)
HK (1) HK1002018A1 (da)
IE (1) IE67345B1 (da)
NO (1) NO305055B1 (da)
NZ (1) NZ241915A (da)
ZA (1) ZA921659B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924617B (en) 1991-03-25 1994-05-27 Boart International S A Pty Lt A percussion drill bit
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US5928668A (en) * 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
BR9509019B1 (pt) * 1994-09-22 2009-01-13 comprimido isento de solventes orgÂnicos.
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
EP0820237A4 (en) * 1995-01-25 1999-01-20 Wrigley W M Jun Co IMPROVED DUST MIXTURE AND METHOD FOR PRODUCING CHEWING GUM WITH YOUR HELP
DK0833642T3 (da) * 1995-06-22 2002-06-10 Akzo Nobel Nv Komprimerede tør-granulerede desogestreltabletter
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
DE19917347A1 (de) 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
ITMI991582A1 (it) * 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
JP2003518038A (ja) * 1999-12-20 2003-06-03 ニコラス， ジェイ カークホフ， 流動床噴霧乾燥によるナノ粒子製造方法
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
JP5033297B2 (ja) * 2000-07-20 2012-09-26 カムピナ・ベスローテン・フェンノートシャップ 結晶性の錠剤化用添加剤の製造方法、それにより得られる添加剤、およびその使用
WO2002047693A2 (en) * 2000-12-14 2002-06-20 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products comprising a stabilizing agent in non-crystalline form
JPWO2002069934A1 (ja) * 2001-03-06 2004-07-02 協和醗酵工業株式会社 口腔内速崩壊性製剤
CA2440365A1 (en) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Use of a spray-dried powder comprising a sugar alcohol
PL366453A1 (en) * 2001-05-01 2005-02-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
JP4898431B2 (ja) 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
TWI356036B (en) * 2004-06-09 2012-01-11 Smithkline Beecham Corp Apparatus and method for pharmaceutical production
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2178540A4 (en) * 2007-08-01 2012-01-04 Stellan Hjerten PHARMACEUTICAL COMPOSITION FOR ADSORBED ON THE CELL SURFACE OF PATHOGENIC MICROBES
AU2009303272A1 (en) * 2008-10-10 2010-04-15 Teva Women's Health, Inc. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
KR101817361B1 (ko) 2009-03-09 2018-01-11 에스피아이 파르마, 인크. 고도 압착성 및 내구성 직접 압축성 부형제 및 부형제 시스템
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
EP2354150A1 (en) * 2010-02-09 2011-08-10 Laboratoire Theramex Process for the preparation of gestodene
WO2012120365A1 (en) 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
CN102416003A (zh) * 2011-12-08 2012-04-18 南京优科生物医药有限公司 一种制备恩替卡韦片剂的方法
CN105307639B (zh) * 2013-03-04 2020-06-30 博赏医药卢森堡责任有限公司 包含与载体颗粒结合的活性剂纳米颗粒的干药物组合物
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US3802914A (en) * 1972-04-10 1974-04-09 Kraftco Corp Method of treating lactose
SE378109B (da) * 1972-05-19 1975-08-18 Bofors Ab
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2524902C2 (de) * 1975-06-02 1984-10-25 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
US4143136A (en) * 1976-11-20 1979-03-06 Akzona Incorporated Method of contraception
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide

Also Published As

Publication number Publication date
CN1064810A (zh) 1992-09-30
DK0503521T4 (da) 2005-12-05
EP0503521B1 (en) 1995-07-19
CA2062428C (en) 2002-07-30
NZ241915A (en) 1994-04-27
CN1039086C (zh) 1998-07-15
NO305055B1 (no) 1999-03-29
ATE125155T1 (de) 1995-08-15
KR920017656A (ko) 1992-10-21
DE69203488D1 (de) 1995-08-24
ZA921659B (en) 1992-11-25
US5382434A (en) 1995-01-17
IE920634A1 (en) 1992-09-23
FI100770B (fi) 1998-02-27
DE69203488T3 (de) 2006-07-06
IE67345B1 (en) 1996-03-20
FI921023A (fi) 1992-09-13
EP0503521A1 (en) 1992-09-16
AU1211992A (en) 1992-09-17
JPH0578251A (ja) 1993-03-30
NO920958L (no) 1992-09-14
JP3474210B2 (ja) 2003-12-08
KR100198017B1 (ko) 1999-06-15
HK1002018A1 (en) 1998-07-24
AU651869B2 (en) 1994-08-04
DE69203488T2 (de) 1996-01-11
EP0503521B2 (en) 2005-11-09
ES2077897T3 (es) 1995-12-01
FI921023A0 (fi) 1992-03-09
NO920958D0 (no) 1992-03-11
CA2062428A1 (en) 1992-09-13
ES2077897T5 (es) 2006-06-16
GR3017737T3 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
DK0503521T4 (da) Törre, farmaceutiske lavdosispræparater
IE891414L (en) Pharmaceutical compositions
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
KR920006909B1 (ko) 니트렌디핀을 함유하는 고상 약제의 제조 방법
NO922807D0 (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
EP0391374A3 (en) Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
DK0456720T3 (da) Granuleringer med højt ibuprofenindhold
KR880004805A (ko) 분무건조된 아세트아미노펜
GB1427881A (en) Mixtures containing nitroglycerin and polyvinyl-pyrrolidone
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
WO2001010415B1 (en) A binder for pharmaceutical compositions
Fateeva Pharmacokinetics of amphoglucamine in an experiment
ATE90555T1 (de) Scleroglucan und wirkstoff enthaltende pharmazeutische tabletten und kapselgranulate.
NO176948C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i enhetsdoseform omfattende finmalt colestipol-hydroklorid
GB1255805A (en) Improvements in delayed release pharmaceutical preparations and stabilisation of vitamins
JPS5462327A (en) Remedy for dna virus infectious disease
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS57176907A (en) Readily absorbable solid pharmaceutical composition of as-56c
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
CA2176461A1 (en) Method for preparing low dose pharmaceutical products
JPS57112328A (en) Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid
NO964775L (no) Fast farmasöytisk adenosinholdig preparat